ReviewCancer innovation2023
Progress in phase III clinical trials of molecular targeted therapy and immunotherapy for glioblastoma.
Yuekun Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it